➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Medtronic
Johnson and Johnson
Boehringer Ingelheim
Baxter

Last Updated: May 18, 2021

DrugPatentWatch Database Preview

Validus Pharms Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for VALIDUS PHARMS, and what generic alternatives to VALIDUS PHARMS drugs are available?

VALIDUS PHARMS has twenty-one approved drugs.

There is one US patent protecting VALIDUS PHARMS drugs.

There is one patent family member on VALIDUS PHARMS drugs in one country and ten supplementary protection certificates in six countries.

Summary for Validus Pharms
International Patents:1
US Patents:1
Tradenames:19
Ingredients:17
NDAs:21

Drugs and US Patents for Validus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms CLAFORAN cefotaxime sodium INJECTABLE;INJECTION 050547-004 Dec 29, 1983 DISCN Yes No   Get Started Free   Get Started Free
Validus Pharms LOTENSIN benazepril hydrochloride TABLET;ORAL 019851-003 Jun 25, 1991 AB RX Yes No   Get Started Free   Get Started Free
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 AB RX Yes No   Get Started Free   Get Started Free
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-007 Feb 11, 1982 AB RX Yes No   Get Started Free   Get Started Free
Validus Pharms TRENTAL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 018631-001 Aug 30, 1984 DISCN Yes No   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Validus Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-001 Approved Prior to Jan 1, 1982 3,697,559   Get Started Free
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-003 Approved Prior to Jan 1, 1982 3,454,698   Get Started Free
Validus Pharms ANZEMET dolasetron mesylate INJECTABLE;INJECTION 020624-001 Sep 11, 1997 4,906,775   Get Started Free
Validus Pharms BUMEX bumetanide TABLET;ORAL 018225-003 Jun 14, 1985 3,634,583   Get Started Free
Validus Pharms ROCALTROL calcitriol CAPSULE;ORAL 018044-002 Approved Prior to Jan 1, 1982 4,225,596   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for VALIDUS PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Capsules 100 mg ➤ Subscribe 2014-05-23
➤ Subscribe Extended-release Capsules 200 mg and 300 mg ➤ Subscribe 2007-08-21

Supplementary Protection Certificates for Validus Pharms Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0565634 06C0030 France   Get Started Free PRODUCT NAME: EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 32075 20060623; FIRST REGISTRATION: LI - 55783 01 20020607
0454511 99C0009 Belgium   Get Started Free PRODUCT NAME: IRBESARTAN / HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/98/086/001 19981015
0480717 98C0025 Belgium   Get Started Free PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215
0454511 SPC/GB99/008 United Kingdom   Get Started Free PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015
0266730 SPC/GB97/005 United Kingdom   Get Started Free PRODUCT NAME: DOLASETRON, OR A PHARMACEUTICALLY-ACCEPTABLE ACID ADDITION OR QUATERNARY AMMONIUM SALT THEREOF; REGISTERED: UK 04425/0150 19960926
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Harvard Business School
Mallinckrodt
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.